Davide Graziani

Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 2. Identification of (<i>S</i>)-<i>N</i>-(1-Phenylpropyl)-3-hydroxy-2- phenylquinoline-4-carboxamide (SB 223412)

Giuseppe Giardina, Luca F. Raveglia, Mario Grugni et al. · Journal of Medicinal Chemistry · 1999 · 63 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Selective δ opioid receptor agonists for inflammatory and neuropathic pain

Giulio Dondio, Silvano Ronzoni, Carlo Farina et al. · Il Farmaco · 2001 · 30 citations

Nursing, Medicinal Chemistry, Pharmacology +14

Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists

Giuseppe Giardina, Marco Artico, Stefano Cavagnera et al. · Il Farmaco · 1999 · 21 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: Discovery and computational modeling of a new series of ligands with nanomolar affinity

Andrew Anighoro, Davide Graziani, Ilaria Bettinelli et al. · Bioorganic & Medicinal Chemistry · 2015 · 15 citations · Full text

Pharmacy, Medicinal Chemistry, Neuroscience +16

The Approach of Conformational Chimeras to Model the Role of Proline‐Containing Helices on GPCR Mobility: the Fertile Case of Cys‐LTR1

Ilaria Bettinelli, Davide Graziani, Cristina Marconi et al. · ChemMedChem · 2011 · 11 citations

Life Sciences, Biochemistry, Molecular Biology +17